Distalmotion is a company based in Switzerland, dedicated to empowering robotic surgery through its innovative product, Dexter. The company's mission is to make robotic surgery more accessible and easier to adopt for hospitals and surgeons globally, thereby providing more patients with access to minimally invasive care. Distalmotion has received De Novo approval from the U. S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult inguinal hernia repair. The Dexter system is designed to be simple, compact, and open-platform, facilitating its integration into clinical workflows and broad adoption across various healthcare facilities. Established in 2012, Distalmotion is committed to setting a new standard of care in the field of robotic surgery.